查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1919212

伊米普林市場按劑型、應用、終端用戶行業和通路分類 - 全球預測 2026-2032

Imiprothrin Market by Form, Mode Of Application, End Use Industry, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025 年，丙咪嗪市場價值為 5.2584 億美元，預計到 2026 年將成長至 5.7135 億美元，預計到 2032 年將達到 10.9521 億美元，複合年成長率為 11.05%。

關鍵市場統計數據
基準年 2025 5.2584億美元
預計年份：2026年 5.7135億美元
預測年份 2032 10.9521億美元
複合年成長率 (%) 11.05%

全面介紹異丙酯在現代害蟲防治策略中的作用：重點闡述其技術特性、法規環境和實際應用。

由於其快速擊倒作用和與多種施用方式的兼容性，咪唑丙酮已成為害蟲防治製劑中的關鍵成分。本文將咪唑丙酮置於病媒控制、家庭害蟲防治和綜合蟲害管理項目的更廣泛背景下進行介紹，說明其技術特性、典型應用案例以及相關的監管環境。了解該化合物的功能作用，尤其是在氣霧劑、蚊香和液體蒸發系統中的作用，將有助於相關人員更好地將產品開發和分銷決策與最終用戶的期望和安全要求相匹配。

藥物研發創新、電子商務的發展以及監管的日益嚴格正在重塑整個產業的研發、分銷和商業策略。

農藥原料市場格局正因技術創新、消費者期望以及監管力道的加強而改變。新型配方技術強調低氣味、減少溶劑用量以及採用協同輸送系統，從而延長藥效持續時間並提升安全性。同時，數位化商務和全通路分銷正在重塑住宅和商用用戶發現和購買害蟲防治產品的方式，也因此更加迫切地需要清晰的產品聲明和檢驗的功效數據。

評估近期關稅調整將如何促進策略採購變革、價格調整和創新，以維持供應鏈韌性和商業性連續性。

關稅政策的變化會對籌資策略、投入成本趨勢和供應商多元化產生直接的連鎖反應。近期關稅調整促使許多企業重新審視其供應商佈局，優先考慮雙重採購和盡可能近岸外包，以降低運輸成本和關稅波動帶來的風險。採購團隊正在調整前置作業時間和庫存緩衝，以減少因關稅突然波動而造成的損失，同時確保依賴異丙苯隆及其相關製劑成分的生產線的供應連續性。

詳細的細分分析揭示了應用類型、終端用戶行業和分銷管道如何以獨特的方式影響配方要求、供應結構和商業化策略。

了解細分市場的細微差別對於最佳化產品設計和分銷策略至關重要。根據應用領域，線圈、霧化器、空間噴霧器和汽化器市場具有顯著不同的市場動態，每種產品都需要特定的配方黏度、輸送機制和暴露控制措施。線圈噴霧器通常需要耐熱粘合劑和緩釋基質，霧化器強調液滴尺寸分佈和快速分散，空間噴霧系統則優先考慮氣溶膠穩定性和推進劑相容性。汽化器應用著重於持續揮發性和劑量控制，以實現長期療效。

美洲、歐洲、中東和非洲以及亞太地區的區域趨勢和監管差異決定了產品設計、分銷策略和合規重點。

區域特徵影響著不同地理區域的監管重點、流通結構和終端用戶偏好。在美洲，法規結構和消費者期望強調清晰的標籤、管控措施以及強大的零售網路，這些網路既支持大眾零售管道，也支持專賣管道，從而為差異化包裝規格和以零售為中心的商品陳列創造了機會。此外，美洲擁有成熟的電子商務生態系統，與傳統的實體店銷售相輔相成，促進了全通路策略的實施，從而實現了跨通路庫存管理和促銷活動的同步。

公司層面的關鍵優勢體現在卓越的配方技術、監管應對力、可擴展的生產能力以及推動商業性差異化的策略通路夥伴關係。

該領域的競爭程度取決於配方技術、監管應對力和分銷管道的綜合實力。主要企業透過持續投資配方科學來提升療效，同時最大限度地降低暴露風險和環境殘留，從而實現差異化競爭。那些優先考慮透明的安全資料包和積極應對監管要求的企業，往往能在複雜的司法管轄區更快進入市場。同樣重要的是，企業必須能夠維持可靠的生產規模和品管，涵蓋從氣霧劑、凝膠到濃縮液液等多種產品形式，因為一致性是贏得零售商信任和終端用戶信賴的基礎。

對領導者的具體建議包括整合研發、監管和商業策略，以增強供應鏈韌性並最佳化全通路上市策略。

產業領導者應優先考慮整合研發、監管和商業職能的策略，以加快產品上市速度，同時確保合規性。投資配方穩健性（降低揮發性、改善用戶體驗和最大限度地減少環境殘留）將提高產品在住宅和機構用戶中的接受度。同步收集監管資訊並儘早與監管機構溝通，可降低核准風險、簡化文書工作，並加速進入複雜的區域市場。

採用透明的混合方法研究途徑（結合監管框架梳理、技術文件審查、專家訪談和情境分析）可確保獲得可操作且可靠的研究結果。

本研究採用混合方法進行綜合分析，結合了同行評審文獻、監管文件、技術安全文件以及對製劑化學、法規事務和通路管理領域專家的結構化訪談。資料收集優先考慮一手資料，以確保符合當前的監管要求和技術規範。同時，輔以行業期刊和行業白皮書等二手資料，以便更好地理解新興的商業趨勢和分銷動態。

策略整合，重點在於平衡配方創新、監管預期和分銷管道執行這三者之間的關係，對於確保長期商業性永續性至關重要。

綜合我們的分析，可以明顯看出，丙咪嗪價值鏈的成功取決於技術創新、監管能力和分銷管道執行三者之間的相互作用。製劑的選擇必須以特定應用的性能要求為導向，同時也要考慮監管預期和最終用戶的偏好。關稅壓力和供應鏈波動正在加速企業向供應商多元化、近岸外包和製劑效率提升的策略轉變，凸顯了採購、研發和商業部門之間跨職能協作的必要性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 亞胺丙酸酯市場依劑型分類

  • 氣霧劑
  • 凝膠
  • 液體

9. 按應用分類的亞胺丙酮市場

  • 蚊香
  • 噴霧器
  • 空間噴霧
  • 蒸發液體

第10章 以最終用途產業分類的丙咪嗪市場

  • 農業
  • 商業的
  • 工業的
  • 住宅

第11章 伊米普林市場按分銷管道分類

  • 離線
    • 便利商店
    • 居家裝潢和DIY專賣店
    • 大賣場和超級市場
    • 專賣店
  • 線上
    • 線上直銷
    • 電子商務平台

第12章 各地區伊米普林市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 亞胺丙酮市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 各國亞胺培南市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章美國亞胺丙酮市場

第16章 中國亞胺丙酮市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Anhui Wynca Chemical Industry Group Co., Ltd.
  • BASF SE
  • Bayer Aktiengesellschaft
  • Corteva Agriscience Corporation
  • Insect Science Limited
  • Jiangsu Yangnong Chemical Co., Ltd.
  • Kedia DS Private Limited
  • Sumitomo Chemical Company, Limited
  • Valent BioSciences LLC
  • Zhejiang Xinan Chemical Industrial Group Co., Ltd.
Product Code: MRR-F14BA1B3413C

The Imiprothrin Market was valued at USD 525.84 million in 2025 and is projected to grow to USD 571.35 million in 2026, with a CAGR of 11.05%, reaching USD 1,095.21 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 525.84 million
Estimated Year [2026] USD 571.35 million
Forecast Year [2032] USD 1,095.21 million
CAGR (%) 11.05%

Comprehensive introduction to imiprothrin's role in modern insect control strategies highlighting technical attributes regulatory context and practical applications

Imiprothrin has emerged as a pivotal ingredient in insect control formulations due to its rapid knockdown effect and compatibility with a range of application formats. This introduction frames imiprothrin within the broader context of vector management, household pest control, and integrated pest management programs, highlighting its technical attributes, typical use cases, and the regulatory environments that govern its deployment. By understanding the compound's functional role-particularly in aerosol, coil, and liquid vaporizing systems-stakeholders can better align product development and distribution decisions with end-user expectations and safety requirements.

The following analysis synthesizes available scientific literature, regulatory guidance, and commercial practice to present a clear, actionable overview for product teams, procurement specialists, and regulatory affairs professionals. It outlines prevailing formulation trends, application innovations, and the interplay between consumer preferences and industrial procurement. Throughout, emphasis is placed on practical implications for manufacturers and distributors, including raw material sourcing considerations, formulation stability challenges, and the need for meticulous labeling and exposure-reduction strategies to meet both consumer safety and compliance objectives.

How innovation in formulations ecommerce growth and intensified regulatory focus are reshaping product development distribution and commercial strategies across the sector

The landscape for insecticide ingredients is shifting as innovation, consumer expectations, and regulatory scrutiny converge. New formulation techniques emphasize lower odor profiles, reduced solvent loads, and synergistic delivery systems that extend residual activity while improving safety perceptions. At the same time, digital commerce and omnichannel distribution have reshaped how household and professional users discover and purchase pest control products, accelerating the need for clear product claims and verifiable efficacy data.

Regulatory scrutiny of active ingredients continues to influence formulation strategies and supply chain decisions, prompting manufacturers to invest in toxicology, exposure modeling, and compliance workflows earlier in the product lifecycle. Concurrently, sustainability considerations are prompting a shift toward reduced packaging waste and exploration of recyclable materials, requiring coordination across product development, procurement, and logistics. These transformative shifts are creating both challenges and opportunities for firms that can adapt their R&D, manufacturing, and go-to-market approaches to prioritize safety, transparency, and user-centric performance.

Assessment of how recent tariff adjustments compel strategic sourcing changes pricing recalibrations and innovation to sustain supply chain resilience and commercial continuity

Tariff policy changes have immediate ripple effects on procurement strategies, input cost dynamics, and supplier diversification. The recent tariff adjustments have prompted many organizations to reassess supplier footprints, prioritizing dual sourcing and nearshoring where possible to mitigate freight and duty volatility. Procurement teams are recalibrating lead times and inventory buffers to reduce exposure to sudden tariff shifts while maintaining continuity of supply for production lines that depend on imiprothrin and related formulation components.

Beyond procurement, tariffs influence pricing strategy and channel margin management. Manufacturers and distributors must balance cost absorption with transparent communication to customers to preserve trust and channel relationships. At the same time, tariff-driven cost increases often accelerate innovation in formulation efficiency, encouraging R&D groups to explore concentration adjustments, alternative solvents, or co-active technologies that maintain performance while reducing reliance on tariff-exposed inputs. Strategic cross-functional alignment across sourcing, regulatory, and commercial teams is essential to translate these pressures into resilient business tactics rather than reactive short-term measures.

Detailed segmentation insights revealing how application modes forms end-use industries and distribution channels uniquely shape formulation requirements supply and commercialization approaches

A nuanced understanding of segmentation is essential to tailor product design and channel strategies. Based on Mode Of Application, market dynamics differ markedly across Coils, Foggers, Space Spray, and Vaporizing Liquid, each demanding specific formulation viscosities, delivery mechanics, and exposure control measures. Coils often require heat-stable binders and controlled-release matrices, whereas Foggers emphasize droplet size distribution and rapid dispersion, and Space Spray systems prioritize aerosol stability and propellant compatibility. Vaporizing Liquid applications focus on sustained volatilization and dosage control to maintain efficacy over extended periods.

Based on Form, formulation choices across Aerosol, Gel, and Liquid carry distinct manufacturing and regulatory implications. Aerosol formats necessitate rigorous propellant selection and can present labeling and transport constraints, gels require careful rheology control and adhesion properties to ensure localized action, and liquid products prioritize solvent systems and emollient balances to achieve desired volatility and substrate compatibility. Based on End Use Industry, requirements vary among Agricultural, Commercial, Industrial, and Residential users, each with divergent performance expectations, regulatory profiles, and procurement channels. Agricultural applications emphasize environmental fate and non-target organism safety, while residential formulations prioritize low odor and ease of use; commercial and industrial buyers often require bulk packaging and consistent supply validation. Based on Distribution Channel, the choice between Offline and Online paths shapes packaging, marketing, and fulfillment strategies. Offline distribution spans Convenience Stores, Hardware And Diy Stores, Hypermarkets And Supermarkets, and Specialty Retailers, each presenting unique merchandising and point-of-sale considerations, whereas Online distribution includes Direct Online Sales and E Commerce Platforms that demand strong digital product content, clear shipping compliance, and optimized fulfillment workflows to maintain customer satisfaction and regulatory adherence.

Regional dynamics and regulatory diversity across the Americas EMEA and Asia-Pacific that determine tailored product design distribution strategies and compliance priorities

Regional dynamics shape regulatory priorities, distribution architectures, and end-user preferences across distinct geographies. In the Americas, regulatory frameworks and consumer expectations emphasize robust labeling, stewardship programs, and a strong retail footprint that supports both large-format retail and specialty channels, creating opportunities for differentiated packaging sizes and retail-ready merchandising. The Americas also demonstrate a mature e-commerce ecosystem that complements traditional brick-and-mortar sales, encouraging omnichannel strategies that sync inventory and promotions across formats.

In Europe, Middle East & Africa, regulatory heterogeneity and climate diversity require adaptable product formulations and versatile safety dossiers. This region often demands rigorous environmental impact assessments and harmonized compliance documentation for cross-border trade. Manufacturers aiming to expand here must invest in region-specific testing and engage proactively with local regulatory authorities. In Asia-Pacific, rapid urbanization, diverse distribution infrastructures, and varying consumer price sensitivities shape product mix and channel priorities. High-density urban centers favor compact, low-odor delivery formats and convenience-focused packaging, while expanding online retail penetration is changing how brands present efficacy claims and deliver product education. Each region therefore requires a tailored combination of regulatory planning, channel development, and product adaptation to meet distinct market dynamics and stakeholder expectations.

Key company-level advantages center on formulation excellence regulatory readiness scalable manufacturing and strategic channel partnerships that drive commercial differentiation

Competitive dynamics in this sector are driven by a combination of formulation expertise, regulatory preparedness, and distribution reach. Leading players differentiate through sustained investment in formulation science that enhances efficacy while minimizing exposure risks and environmental persistence. Companies that prioritize transparent safety data packages and proactive regulatory engagement tend to achieve faster market access in complex jurisdictions. Equally important is the ability to scale production reliably and maintain quality control across multiple product forms, from aerosols to gels to liquid concentrates, since consistency underpins both retailer trust and end-user confidence.

Strategic partnerships and channel relationships are another axis of competitive advantage. Firms that cultivate strong relationships with large-format retailers, specialty distributors, and digital marketplaces secure better shelf placement and promotional support, which amplifies brand visibility. Additionally, investments in post-market surveillance and customer feedback loops enable iterative product improvements and rapid response to performance concerns. Finally, companies that embed sustainability and waste-reduction measures into packaging and logistics gain reputational benefits and meet evolving regulatory and consumer expectations, distinguishing their offerings in a crowded field.

Actionable recommendations for leaders to align R&D regulatory and commercial strategies enhance supply resilience and optimize omnichannel go-to-market approaches

Industry leaders should prioritize an integrated approach that aligns R&D, regulatory, and commercial functions to accelerate time-to-market while maintaining compliance. Investment in formulation robustness-targeting lower volatility, improved user experience, and minimized environmental persistence-will enhance product acceptability across residential and institutional users. Parallel efforts in regulatory intelligence and early engagement with authorities can de-risk approvals and streamline documentation, enabling faster entry into complex regional markets.

From a commercial perspective, optimizing the balance between offline and online distribution is imperative. Strengthening relationships with specialty retailers and major brick-and-mortar chains should be complemented by enhanced digital product content and fulfillment capabilities for e-commerce channels. Supply chain resilience requires diversified sourcing strategies, contingency stock planning, and collaboration with logistics partners to cushion the impact of tariff fluctuations and transport disruptions. Finally, companies should implement post-launch monitoring frameworks that capture real-world performance and safety signals, feeding those insights back into iterative formulation and labeling improvements to preserve brand trust and regulatory compliance.

Transparent mixed-methods research approach combining regulatory mapping technical dossier review expert interviews and scenario analysis to ensure actionable and credible findings

This research synthesis draws on a mixed-methods approach that integrates peer-reviewed literature, regulatory filings, technical safety dossiers, and structured interviews with subject-matter experts across formulation chemistry, regulatory affairs, and channel management. Data collection prioritized primary source documents to ensure fidelity to current regulatory requirements and technical specifications. Supplementary secondary sources, including trade publications and industry whitepapers, were used to contextualize emerging commercial trends and distribution dynamics.

Analytical methods included comparative regulatory mapping to identify jurisdictional variances, formulation risk profiling to assess compatibility with different application modes and forms, and scenario analysis to explore the operational impact of tariffs and supply disruptions. Expert interviews were used to validate assumptions, surface practical constraints faced by manufacturers and distributors, and prioritize actionable recommendations. The methodology emphasizes transparency and traceability, with assertions grounded in documented regulatory guidance and corroborated by multiple independent expert perspectives to enhance credibility and practical relevance.

Strategic synthesis emphasizing the essential balance of formulation innovation regulatory foresight and channel execution to secure long-term commercial viability

In consolidating the analysis, it is clear that success in the imiprothrin value chain depends on the interplay between technical innovation, regulatory acumen, and channel execution. Formulation choices must be driven by application-specific performance needs while anticipating regulatory expectations and end-user preferences. Tariff pressures and supply chain volatility are accelerating strategic shifts toward supplier diversification, nearshoring, and formulation efficiency improvements, underscoring the need for cross-functional coordination across sourcing, R&D, and commercial teams.

Looking forward, organizations that embed regulatory foresight, invest in formulation science for safer and more user-friendly products, and execute coherent omnichannel strategies will be best positioned to capture commercial opportunities and mitigate downside risk. Continuous monitoring of post-market performance and a willingness to iterate based on real-world data will preserve trust and ensure long-term viability across residential, commercial, industrial, and agricultural segments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Imiprothrin Market, by Form

  • 8.1. Aerosol
  • 8.2. Gel
  • 8.3. Liquid

9. Imiprothrin Market, by Mode Of Application

  • 9.1. Coils
  • 9.2. Foggers
  • 9.3. Space Spray
  • 9.4. Vaporizing Liquid

10. Imiprothrin Market, by End Use Industry

  • 10.1. Agricultural
  • 10.2. Commercial
  • 10.3. Industrial
  • 10.4. Residential

11. Imiprothrin Market, by Distribution Channel

  • 11.1. Offline
    • 11.1.1. Convenience Stores
    • 11.1.2. Hardware And Diy Stores
    • 11.1.3. Hypermarkets And Supermarkets
    • 11.1.4. Specialty Retailers
  • 11.2. Online
    • 11.2.1. Direct Online Sales
    • 11.2.2. E Commerce Platforms

12. Imiprothrin Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Imiprothrin Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Imiprothrin Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Imiprothrin Market

16. China Imiprothrin Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Anhui Wynca Chemical Industry Group Co., Ltd.
  • 17.6. BASF SE
  • 17.7. Bayer Aktiengesellschaft
  • 17.8. Corteva Agriscience Corporation
  • 17.9. Insect Science Limited
  • 17.10. Jiangsu Yangnong Chemical Co., Ltd.
  • 17.11. Kedia DS Private Limited
  • 17.12. Sumitomo Chemical Company, Limited
  • 17.13. Valent BioSciences LLC
  • 17.14. Zhejiang Xinan Chemical Industrial Group Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL IMIPROTHRIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL IMIPROTHRIN MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL IMIPROTHRIN MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL IMIPROTHRIN MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL IMIPROTHRIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL IMIPROTHRIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES IMIPROTHRIN MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA IMIPROTHRIN MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL IMIPROTHRIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL IMIPROTHRIN MARKET SIZE, BY AEROSOL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL IMIPROTHRIN MARKET SIZE, BY AEROSOL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL IMIPROTHRIN MARKET SIZE, BY AEROSOL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL IMIPROTHRIN MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL IMIPROTHRIN MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL IMIPROTHRIN MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL IMIPROTHRIN MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL IMIPROTHRIN MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL IMIPROTHRIN MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL IMIPROTHRIN MARKET SIZE, BY COILS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL IMIPROTHRIN MARKET SIZE, BY COILS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL IMIPROTHRIN MARKET SIZE, BY COILS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL IMIPROTHRIN MARKET SIZE, BY FOGGERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL IMIPROTHRIN MARKET SIZE, BY FOGGERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IMIPROTHRIN MARKET SIZE, BY FOGGERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMIPROTHRIN MARKET SIZE, BY SPACE SPRAY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IMIPROTHRIN MARKET SIZE, BY SPACE SPRAY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL IMIPROTHRIN MARKET SIZE, BY SPACE SPRAY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL IMIPROTHRIN MARKET SIZE, BY VAPORIZING LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL IMIPROTHRIN MARKET SIZE, BY VAPORIZING LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL IMIPROTHRIN MARKET SIZE, BY VAPORIZING LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL IMIPROTHRIN MARKET SIZE, BY AGRICULTURAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL IMIPROTHRIN MARKET SIZE, BY AGRICULTURAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL IMIPROTHRIN MARKET SIZE, BY AGRICULTURAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL IMIPROTHRIN MARKET SIZE, BY COMMERCIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL IMIPROTHRIN MARKET SIZE, BY COMMERCIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL IMIPROTHRIN MARKET SIZE, BY COMMERCIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL IMIPROTHRIN MARKET SIZE, BY INDUSTRIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMIPROTHRIN MARKET SIZE, BY INDUSTRIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IMIPROTHRIN MARKET SIZE, BY INDUSTRIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMIPROTHRIN MARKET SIZE, BY RESIDENTIAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL IMIPROTHRIN MARKET SIZE, BY RESIDENTIAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL IMIPROTHRIN MARKET SIZE, BY RESIDENTIAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL IMIPROTHRIN MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL IMIPROTHRIN MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL IMIPROTHRIN MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL IMIPROTHRIN MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL IMIPROTHRIN MARKET SIZE, BY CONVENIENCE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL IMIPROTHRIN MARKET SIZE, BY CONVENIENCE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL IMIPROTHRIN MARKET SIZE, BY HARDWARE AND DIY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL IMIPROTHRIN MARKET SIZE, BY HARDWARE AND DIY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL IMIPROTHRIN MARKET SIZE, BY HARDWARE AND DIY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL IMIPROTHRIN MARKET SIZE, BY HYPERMARKETS AND SUPERMARKETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL IMIPROTHRIN MARKET SIZE, BY HYPERMARKETS AND SUPERMARKETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL IMIPROTHRIN MARKET SIZE, BY HYPERMARKETS AND SUPERMARKETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL IMIPROTHRIN MARKET SIZE, BY SPECIALTY RETAILERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL IMIPROTHRIN MARKET SIZE, BY SPECIALTY RETAILERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL IMIPROTHRIN MARKET SIZE, BY SPECIALTY RETAILERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL IMIPROTHRIN MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL IMIPROTHRIN MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL IMIPROTHRIN MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL IMIPROTHRIN MARKET SIZE, BY DIRECT ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL IMIPROTHRIN MARKET SIZE, BY DIRECT ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL IMIPROTHRIN MARKET SIZE, BY DIRECT ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL IMIPROTHRIN MARKET SIZE, BY E COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL IMIPROTHRIN MARKET SIZE, BY E COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL IMIPROTHRIN MARKET SIZE, BY E COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL IMIPROTHRIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS IMIPROTHRIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 67. AMERICAS IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 68. AMERICAS IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 69. AMERICAS IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 70. AMERICAS IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. AMERICAS IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 72. AMERICAS IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. NORTH AMERICA IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 75. NORTH AMERICA IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. NORTH AMERICA IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 77. NORTH AMERICA IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 78. NORTH AMERICA IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 79. NORTH AMERICA IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. LATIN AMERICA IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 82. LATIN AMERICA IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 83. LATIN AMERICA IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 84. LATIN AMERICA IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 85. LATIN AMERICA IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 86. LATIN AMERICA IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA IMIPROTHRIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE, MIDDLE EAST & AFRICA IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE, MIDDLE EAST & AFRICA IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE, MIDDLE EAST & AFRICA IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE, MIDDLE EAST & AFRICA IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE, MIDDLE EAST & AFRICA IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE, MIDDLE EAST & AFRICA IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. EUROPE IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. MIDDLE EAST IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 103. MIDDLE EAST IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 104. MIDDLE EAST IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 105. MIDDLE EAST IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 106. MIDDLE EAST IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 107. MIDDLE EAST IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. AFRICA IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 110. AFRICA IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 111. AFRICA IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 112. AFRICA IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 113. AFRICA IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 114. AFRICA IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. ASIA-PACIFIC IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 117. ASIA-PACIFIC IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. ASIA-PACIFIC IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL IMIPROTHRIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. ASEAN IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 125. ASEAN IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 126. ASEAN IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 127. ASEAN IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. ASEAN IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 129. ASEAN IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 130. GCC IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GCC IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 132. GCC IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. GCC IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GCC IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. GCC IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 136. GCC IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPEAN UNION IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPEAN UNION IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPEAN UNION IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPEAN UNION IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPEAN UNION IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPEAN UNION IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 145. BRICS IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 146. BRICS IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 147. BRICS IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 148. BRICS IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 149. BRICS IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 150. BRICS IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 151. G7 IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 152. G7 IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 153. G7 IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. G7 IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 155. G7 IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. G7 IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 157. G7 IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 158. NATO IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. NATO IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 160. NATO IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. NATO IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 162. NATO IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. NATO IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 164. NATO IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL IMIPROTHRIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES IMIPROTHRIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 167. UNITED STATES IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 168. UNITED STATES IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 169. UNITED STATES IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 170. UNITED STATES IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. UNITED STATES IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 172. UNITED STATES IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA IMIPROTHRIN MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 174. CHINA IMIPROTHRIN MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 175. CHINA IMIPROTHRIN MARKET SIZE, BY MODE OF APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 176. CHINA IMIPROTHRIN MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 177. CHINA IMIPROTHRIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. CHINA IMIPROTHRIN MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 179. CHINA IMIPROTHRIN MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)